Technology allows visually impaired to enjoy TV

Article

People with low vision can improve their ability to watch television with a new technique that allows them to enhance the contrast of images of people and objects of interest on their digital televisions.

People with low vision can improve their ability to watch television with a new technique that allows them to enhance the contrast of images of people and objects of interest on their digital televisions, according to a report in the January issue of the Journal of the Optical Society of America.

The new method, developed by the Institute's low vision expert Dr Eli Peli, involves making simple changes within the "decoders" of digital televisions, which improves the contrast enhancement. To test the technology, the research team presented eight digital videos to 24 subjects with vision impairment and six with normal vision. Each patient was given a remote control, which allowed him/her to increase or decrease the contrast of the image.

The researchers found that even subjects with normal vision selected some enhancement and that the amount of enhancement selected by those with visual impairment varied depending upon the level of contrast sensitivity loss they experienced due to their disease.

Dr Peli is now working with US firm Analog Devices Inc, to create a prototype chip that could be included in future generations of digital televisions.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.